Sunday, September 30, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news Lupin aims to double sales in Japan to $500 million in next 5 yearsEconomic TimesThe Mumbai-headquartered firm, which is present in Japan through two wholly-owned subsidiaries -- Kyowa Pharmaceutical Industry and I'rom Pharmaceuticals -- is aiming sales of $250 million (over Rs 1,300 crore) from the country this fiscal. In order to ...See all stories on this topic »New drug pricing policy may impact MNCs most: AnalystsEconomic TimesStill a market-based policy is a balanced formula and will help improve the availability of essential medicines for patients," Organisation of Pharmaceutical Producers of India (OPPI) president and Novartis India vice-chairman and managing director ...See all stories...

Saturday, September 29, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news Bringing more essential drugs under control a fair policy: CIIEconomic TimesWhile the industry welcomes this move, it would also be pertinent to note that the proposed policy will expand the span of price control to around 30 per cent of the domestic pharmaceutical market and impact revenues of the industry which is already ...See all stories on this topic »Shengtai Pharmaceutical, Inc. Reports Financial Results for the Fiscal Year 2012Sacramento Bee"We are very glad that the Company has made some important improvements in the year ended June 30, 2012," stated Qingtai Liu, CEO of Shengtai Pharmaceutical, Inc., "The Company developed a new product, corn germ meal, which can be used as animal ...See...

Friday, September 28, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news Tianyin Pharmaceutical sales decrease 26.9% to $69.6 million for fiscal year 2012News-Medical.netTianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced ...See all stories on this topic »Questcor Pharmaceuticals Initiates Quarterly Cash Dividend and Expands Stock ...Equities.com28, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that its Board of Directors has adopted a policy to pay a regular quarterly dividend in such amounts as the Board of Directors may determine from time...

Thursday, September 27, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news Pharma GoM finalises pricing policy, to cover 348 'essential drugs'Economic TimesAt present, the government through the National Pharmaceutical Pricing Authority (NPPA), controls prices of 74 bulk drugs and their formulations. Fertilisers and Chemicals Minister Srikant Jena said the GoM arrived at a consensus on the option which ...See all stories on this topic »Economic TimesPeople on the move: jobs in pharmaIn-PharmaTechnologist.comin-PharmaTechnologist.com presents its weekly round-up of the lates new appointments in the pharmaceutical world, including news from Capsugel, Shire and Savient. Capsugel has appointed Donal Loughrey senior VP of operations and supply chain.See all stories on this...

Wednesday, September 26, 2012

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news Shanghai Pharmaceuticals to market Aerocrine's instrument NIOX MINO and test ...pharmabiz.comSPH is China's third largest pharmaceutical company with more than 37,000 employees and an annual turnover exceeding 54 billion RMB (approximately 55 billion SEK or US$ 8.5 billion). The company, which is partly state owned, manufactures and markets ...See all stories on this topic »NovaBay Pharmaceuticals (NBY) Receives $2.6 Million From Partner GaldermaStockhouse26, 2012 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE:NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary ...See all stories on this topic »Major Pharmaceutical...

Tuesday, September 25, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news Mallinckrodt Announces Definitive Agreement to Acquire CNS Therapeutics, Inc.MoneylifeMallinckrodt, the Pharmaceuticals business of Covidien (NYSE: COV), has announced a definitive agreement to acquire CNS Therapeutics, Inc., a privately held specialty pharmaceutical company focused on developing and commercializing products for ...See all stories on this topic »Pharmaceuticals Wholesaling in Australia Industry Market Research Report Now ...RedOrbitPharmaceuticals Wholesaling industry growth rates have slowed in line with changes to the industry's operating environment and slower growth in the Pharmaceutical Benefits Scheme. The Pharmaceuticals Wholesaling industry has also been influenced by ...See...

Monday, September 24, 2012

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news Valeant Pharmaceuticals buying Visudyne treatment for blindness from QLTCanadianBusiness.comValeant, which has acquired numerous products and companies since it absorbed the former Biovail pharmaceutical business, said Monday that it sees Visudyne as a valuable addition to the company's ophthalmology business. "Not only will we be able to ...See all stories on this topic »Moody's upgrades pharmaceutical industry to stableBusinessweekWASHINGTON (AP) — Moody's Investors Service upgraded its outlook for the global pharmaceutical industry on Monday, saying the multiyear wave of drug patent expirations that have squeezed profits should subside next year. The ratings service upgraded ...See all stories on this topic »Savient Pharmaceuticals Names John...

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost